Anlon Q1 PAT up 35% standalone; board clears share swap for subsidiaries

Pat Growth 25pctRevenue DeclineEbitda Margin ExpansionResults View source PDF Explain this filing

AHCL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-8.2%Reaction day

₹15.90

prior close

₹15.67

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.6%-7.7% vs market

Pharmaceuticals peers, median of 162sector-0.7%-7.5% vs sector

On the reaction day the stock moved 7.7 pts less than Nifty Microcap 250 and 7.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.8

10m

-7.1

15m

-6.8

30m

-7.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-8.2-0.6-7.7-0.7-7.5

Next day

-8.1+0.5-8.6-0.5-7.6

-7.2+1.9-9.1+0.2-7.4

-8.2+2.3-10.5+0.1-8.3

-8.4+3.6-12.0+0.5-8.9

-11.1+4.0-15.1+0.7-11.8

-9.1+4.0-13.1+1.4-10.5

15d

-9.6+4.9-14.5+0.4-10.0

-0.1+5.9-6.0+1.7-1.8

+117.5+4.8+112.7+2.7+114.8

+63.3pendingpending-3.1+66.3

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Q1 FY27 standalone PAT rose 35% to Rs 479.71 lakh on Rs 3,097.56 lakh revenue (down 7% YoY). Consolidated PAT jumped 133% to Rs 828.14 lakh on Rs 8,756.27 lakh revenue (includes subsidiaries). Board approved share swap to acquire remaining stakes in Apiqo Organics (32.52%) and Bizotic LifeScience (43.33%), making them wholly owned subsidiaries. All IPO proceeds fully utilized. Auditor issued an unqualified review report.

Likely market impact

Standalone profit growth despite revenue dip shows margin improvement. Consolidation of AOPL and BLPL will further lift consolidated earnings.